DK3278811T3 - Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade - Google Patents

Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade Download PDF

Info

Publication number
DK3278811T3
DK3278811T3 DK17187879.6T DK17187879T DK3278811T3 DK 3278811 T3 DK3278811 T3 DK 3278811T3 DK 17187879 T DK17187879 T DK 17187879T DK 3278811 T3 DK3278811 T3 DK 3278811T3
Authority
DK
Denmark
Prior art keywords
ggf2
treatment
peripheral nervous
neuropatic pain
nervous injury
Prior art date
Application number
DK17187879.6T
Other languages
English (en)
Inventor
Anthony O Caggiano
Anthony J Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Application granted granted Critical
Publication of DK3278811T3 publication Critical patent/DK3278811T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK17187879.6T 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade DK3278811T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693589P 2012-08-27 2012-08-27
US201261693585P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
EP13716919.9A EP2830645B1 (en) 2012-03-30 2013-03-29 Neuregulin for use in treating peripheral nerve injury

Publications (1)

Publication Number Publication Date
DK3278811T3 true DK3278811T3 (da) 2021-03-01

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13716919.9T DK2830645T3 (da) 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion
DK17187879.6T DK3278811T3 (da) 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13716919.9T DK2830645T3 (da) 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion

Country Status (16)

Country Link
US (3) US20150094263A1 (da)
EP (3) EP3842059A1 (da)
JP (4) JP6420233B2 (da)
CN (2) CN104321072A (da)
AU (4) AU2013237896B2 (da)
BR (1) BR112014024308B1 (da)
CA (1) CA2869070A1 (da)
DK (2) DK2830645T3 (da)
ES (2) ES2857810T3 (da)
HK (2) HK1206632A1 (da)
IL (3) IL288785B2 (da)
MX (1) MX354598B (da)
NZ (1) NZ700546A (da)
PL (2) PL3278811T3 (da)
PT (2) PT3278811T (da)
WO (1) WO2013149163A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5797112B2 (ja) 2008-07-17 2015-10-21 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはそのサブ配列の治療的投与方法
EP2813238B1 (en) 2009-10-14 2017-05-03 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL259752B (en) * 2015-12-04 2022-07-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
CA3082878C (en) 2017-11-17 2024-02-20 The Research Foundation for State University of New York A method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
US20220277853A1 (en) * 2019-08-01 2022-09-01 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
AU745324B2 (en) * 1997-10-14 2002-03-21 Cenes Pharmaceuticals, Inc. Therapeutic methods comprising use of a neuregulin
AU7494701A (en) * 2000-05-23 2001-12-03 Cenes Pharmaceuticals Inc Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2009046453A2 (en) * 2007-10-05 2009-04-09 New England Medical Center (Nemc) Use of neuregulin-1 in reducing brain damage
WO2009108390A2 (en) * 2008-02-29 2009-09-03 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
JP5797112B2 (ja) * 2008-07-17 2015-10-21 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはそのサブ配列の治療的投与方法
EP2428211A4 (en) * 2009-05-07 2013-04-03 Moon & J Inc PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURAL DAMAGE AND NEUROLOGICAL DISEASES
EP2813238B1 (en) * 2009-10-14 2017-05-03 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
WO2012021818A2 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
DK2830645T3 (da) 2017-11-20
HK1249038A1 (zh) 2018-10-26
EP3842059A1 (en) 2021-06-30
AU2018200592A1 (en) 2018-02-15
EP3278811A1 (en) 2018-02-07
ES2857810T3 (es) 2021-09-29
EP3278811B1 (en) 2020-12-02
PT2830645T (pt) 2017-11-28
BR112014024308A8 (pt) 2018-01-23
IL273186A (en) 2020-04-30
AU2020260539A1 (en) 2020-11-26
IL234882B (en) 2020-03-31
ES2647917T3 (es) 2017-12-27
IL288785B2 (en) 2023-03-01
AU2019202401B2 (en) 2020-10-15
MX354598B (es) 2018-03-12
IL288785A (en) 2022-02-01
IL234882A0 (en) 2014-12-31
IL288785B (en) 2022-11-01
AU2013237896B2 (en) 2017-11-02
JP2015514096A (ja) 2015-05-18
CN106511971A (zh) 2017-03-22
AU2013237896A1 (en) 2014-10-16
JP2021059605A (ja) 2021-04-15
PT3278811T (pt) 2021-03-03
IL273186B (en) 2022-01-01
EP2830645B1 (en) 2017-08-30
EP2830645A1 (en) 2015-02-04
JP2017149746A (ja) 2017-08-31
PL3278811T3 (pl) 2021-08-02
CA2869070A1 (en) 2013-10-03
JP6420233B2 (ja) 2018-11-07
BR112014024308A2 (pt) 2017-08-08
AU2019202401A1 (en) 2019-05-02
NZ700546A (en) 2017-05-26
BR112014024308B1 (pt) 2021-11-30
MX2014011838A (es) 2015-03-09
JP2019131582A (ja) 2019-08-08
JP7108724B2 (ja) 2022-07-28
US20230117985A1 (en) 2023-04-20
HK1206632A1 (en) 2016-01-15
PL2830645T3 (pl) 2018-01-31
US20160346353A1 (en) 2016-12-01
US20150094263A1 (en) 2015-04-02
CN104321072A (zh) 2015-01-28
WO2013149163A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
DK3278811T3 (da) Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade
DK2836200T3 (da) Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
IL263661A (en) Combination therapy for the treatment of glioblastoma
EP2868283A4 (en) THERAPEUTIC TREATMENT DEVICE
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
EP2819703A4 (en) TREATMENT OF PAIN
DK2830662T3 (da) Fremgangsmåder til behandlng af hårtabsforstyrrelser
DK2877184T3 (da) Sammensætninger og behandling for øjensygdomme og -lidelser
SG11201500685PA (en) Warm-cool beauty treatment device
EP2906208A4 (en) THERAPEUTIC TREATMENT
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
DK2827813T3 (da) Kuldebehandlingsindretning
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur
EP2939625A4 (en) THERAPEUTIC TREATMENT DEVICE
HK1209424A1 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury
DK2782566T3 (da) L-serin til anvendelse ved behandling af neurodegenerative lidelser
HK1207593A1 (en) Medicament for treating mental and behavioural disorders
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents